Cargando…
Capsaicin binds the N-terminus of Hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin)
Heat shock protein 90 (Hsp90) and its co-chaperones promote cancer, and targeting Hsp90 holds promise for cancer treatment. Most of the efforts to harness this potential have focused on targeting the Hsp90 N-terminus ATP binding site. Although newer-generation inhibitors have shown improved efficacy...
Autores principales: | Patwardhan, Chaitanya A., Kommalapati, Vamsi Krishna, Llbiyi, Taoufik, Singh, Digvijay, Alfa, Eyad, Horuzsko, Anatolij, Korkaya, Hasan, Panda, Siva, Reilly, Christopher A., Popik, Vladimir, Chadli, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447550/ https://www.ncbi.nlm.nih.gov/pubmed/37612326 http://dx.doi.org/10.1038/s41598-023-40933-9 |
Ejemplares similares
-
Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX
por: Powers, Marissa V, et al.
Publicado: (2013) -
Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer
por: Eisa, Nada H., et al.
Publicado: (2023) -
HSP90 inhibitor 17AAG attenuates sevoflurane-induced neurotoxicity in rats and human neuroglioma cells via induction of HSP70
por: Liu, Min, et al.
Publicado: (2020) -
Repercussion of Mitochondria Deformity Induced by Anti-Hsp90 Drug 17AAG in Human Tumor Cells
por: Vishal, Chaturvedi, et al.
Publicado: (2011) -
Can RNAi-mediated hsp90α knockdown in combination with 17-AAG be a therapy for glioma?()
por: Mehta, Adi, et al.
Publicado: (2013)